dorfmanmaster

Crispr - DNA/Gene editing

Long
NASDAQ:CRSP   CRISPR Therapeutics AG
Technical Analysis
Since early December, we have had over a dozen tails on the purple up-trend arrow drawn in.

The 50sma is now coming into play, as a break below that, could take us another 20% down to the 100sma.
An appropriate level to exit the trade then, would be below the 50sma.

There also horizontal support as we fill the gap.

Important Note:
Earnings are on February 10th; so be aware of this if you plan to enter the trade.


Opinion
I believe this company is the future of gene editing.

Check out a documentary of the company on Netflix called Human Nature.
*It is more about how Crispr (DNA modification) works, than how the company makes money.


Enjoy your weekend,
dorfmaester

Comments

Home Stock Screener Forex Screener Crypto Screener Economic Calendar About Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter